Journal Club
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
0
IAVI-W001 Study Launched at the KAVI-Institute of Clinical Research
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
0
AstraZeneca Awards KAVI-ICR–KNH Partnership Grant for BRCA Cancer Genomics Study
Every year, hundreds of women and men walk into Kenyatta National Hospital (KNH) with breast, ovarian, or prostate cancer. Some of them carry a BRCA1 or BRCA2 mutation, a genetic marker that could open the door to life-extending treatment but many may never know. The test that would tell them is cost-prohibitive, and it is not routinely offered in public hospitals in Kenya.